You can find the annual or quarterly income statement of aTyr Pharma Ord Shs here for insights into the performance and operational efficiency of aTyr Pharma Ord Shs.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
Total revenue
--193.10M
--110.08M
--93.79M
Revenue
--193.10M
--110.08M
--93.79M
Cost of revenue
--4.60M
--3.34M
--3.01M
Operating expenses
--356.41M
--85.61M
--76.72M
R&D expenses
----
----
--22.13M
Depreciation, depletion, and amortization
--1.37M
--1.28M
--1.33M
Operating profit
---163.31M
--24.47M
--17.07M
Net non-operating interest income (expenses)
Non-operating interest income
--1.38M
--1.36M
--1.41M
Non-operating interest expense
--662.00K
--765.00K
--786.00K
Other non-operating income (expenses)
--53.00K
--61.00K
--42.00K
Income before tax
---162.55M
--25.13M
--17.74M
Income tax
--3.85M
--564.00K
--1.86M
Income after tax
---166.39M
--24.56M
--15.87M
Net income from continuous operations
---166.39M
--24.56M
--15.87M
Other net gains and losses
---11.28M
--9.19M
----
Net Income attributable to non-controlling interests
----
----
---2.00K
Net income attributable to controlling interests
---172.03M
--24.56M
--15.87M
Preferred share dividend
--5.64M
----
----
Net income attributable to common shareholders
---172.03M
--24.56M
--15.87M
Basic earnings per share
---3.57
--0.39
--0.25
Diluted earnings per share
---3.57
--0.39
--0.25
Dividend per share
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
Audit opinions
--
--
--
FAQs
What is the income statement?
The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.